Journal of Antimicrobial Chemotherapy (2002) 50, 375-382
© 2002 The British Society for Antimicrobial Chemotherapy
Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients
Department of Infectious Diseases and Microbiology, Catholic University, Largo A. Gemelli 8, 00168 Roma, Italy
Received 19 November 2001; returned 26 March 2002; revised 25 April 2002; accepted 24 May 2002
Objectives: To define the incidence, risk factors and short-term predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients.
Patients and methods: All HIV-infected subjects with S. aureus bacteraemia were consecutively enrolled in a case–control study between January 1, 1991 and December 31, 2000 and prospectively followed up.
Results: In the study period, 129 of 419 (31%) HIV-infected patients with bacteraemia had a diagnosis of S. aureus bacteraemia. The comparative analysis of incidence of S. aureus bacteraemia in the period 1991–96 and 1997–2000 showed a significant decrease (P < 0.001). The same trend was observed for MRSA bacteraemia (P = 0.002). The analysis of antimicrobial resistance showed that among 129 S. aureus strains, 88 (68%) were methicillin susceptible and 41 (32%) were methicillin resistant. The majority of MRSA bacteraemia was hospital acquired (78%). Previous administration of ß-lactams (P < 0.001), multiple previous hospital admissions (P < 0.001) and low numbers of CD4+ peripheral cells (P < 0.001) were found to be independent risk factors of methicillin resistance at multivariate analysis. The mortality rate was 34% in the cases and 11% in the controls (P = 0.002). Multivariate analysis indicated that a high Acute Physiology and Chronic Health Evaluation (APACHE) III score (P < 0.001) and high HIV viraemia (P = 0.02), but not methicillin resistance, predicted an increased risk of death in patients with S. aureus bacteraemia.
Conclusion: Individual exposure to ß-lactams, in association with a history of multiple hospitalizations and low CD4+ cell number, plays a pivotal role as a risk factor for the development of methicillin resistance in HIV-infected patients. Methicillin resistance does not influence the outcome of S. aureus bacteraemia when included in a multivariate analysis.
* Corresponding author. Tel: +39-06-30155373; Fax: +39-06-3054519; E-mail: tumbarello{at}rm.unicatt.it
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  HIV and Community-Acquired MRSA AIDS Clinical Care, February 9, 2009; 2009(209): 1 - 1. [Full Text]
|
|
|
|
 |
|
 E. Tacconelli, G. De Angelis, M. A. Cataldo, E. Pozzi, and R. Cauda Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis J. Antimicrob. Chemother., January 1, 2008; 61(1): 26 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Combes, C.-E. Luyt, J.-Y. Fagon, M. Wollf, J.-L. Trouillet, C. Gibert, and J. Chastre Impact of Methicillin Resistance on Outcome of Staphylococcus aureus Ventilator-associated Pneumonia Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 786 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Risk Factors and Prognosis for MRSA Bacteremia in HIV-Positive Patients Journal Watch Infectious Diseases, November 8, 2002; 2002(1108): 7 - 7. [Full Text]
|
|